Chandresh Harjivan | Special Assistant to the President, Domestic Preparedness and Response to Biological Threats
Office of Pandemic Preparedness and Response Policy (OPPR), Executive Office of The President (EOP)

Chan Harjivan is the currently the Special Assistant to the President, Associate Director for Domestic Preparedness and Response to Pandemics and Biological Threats in the Office of Pandemic Preparedness and Response Policy (OPPR) in the Executive Office of the President at the White House.
With experience in management consulting, leading a successful biotech start-up and now public service, he combines his clinical expertise with a Doctor of Pharmacy, population health acumen with a Master’s in Public Health, and business management with an MBA to provide a holistic approach to protect and preserve the health of populations globally; accelerate the development and access to health care innovations; and strategies for health focused organizations to achieve mission objectives.
Prior to his current role, Chan was the President and Chief Operating Officer at SaponiQx, a biotech company enabling the development of vaccines through the expansion of saponin based adjuvants using generative design and synthetic biology. Prior to joining SaponiQx, Chan was an equity Partner at Boston Consulting Group, and PwC where he led the Global Public Health Practice. He also led Management Consulting for PwC’s Public Sector Practice overseeing the Strategy, Operations, Customer, People and Change and Finance capabilities. With deep content knowledge and breadth of experience, Chan led strategy work across a spectrum of organizations including the largest Multi-laterals, Foundations, NGOs, Pharma and Biotech, as well as most health focused US government agencies and departments.
He has served on many boards, including the Global Health Council, FINCA, and various roles at the Johns Hopkins School of Public Health. Chan has chaired/presented at many conferences and have been quoted or had articles in The Wall Street Journal, Forbes, The Financial Times, Homeland Security, Modern Healthcare, World Economic Forum, Vanity Fair, Esquire and many others about health strategy in the public and private